Page last updated: 2024-10-28

hexamethonium and Suffocation

hexamethonium has been researched along with Suffocation in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research Excerpts

ExcerptRelevanceReference
" The changes of the electric pattern induced by pharmacological administrations of atropine, prostigmine, hexamethonium and by asphyxia suggest that the electric activity is myogenic in origin."3.66[Esophageal EMG activity in the pigeon (Columbia livia) in vivo]. ( Abbadessa Urso, S; Fileccia, R; Gambino, MC; Mulè, F; Postorino, A; Serio, R, 1981)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbadessa Urso, S1
Fileccia, R1
Postorino, A1
Gambino, MC1
Mulè, F1
Serio, R1

Other Studies

1 other study available for hexamethonium and Suffocation

ArticleYear
[Esophageal EMG activity in the pigeon (Columbia livia) in vivo].
    Bollettino della Societa italiana di biologia sperimentale, 1981, Jul-30, Volume: 57, Issue:14

    Topics: Animals; Asphyxia; Atropine; Columbidae; Electromyography; Esophagus; Hexamethonium; Hexamethonium C

1981